An analysis of 2313 reports of pancreatitis associated with hypoglycemic agents found a predominant link with GLP-1RAs compared to DPP-4 inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors. The gene discussed is SLC5A2; the disease is pancreatitis.